HEA – Michmutters
Categories
US

US Senate approves bill to fight climate change, cut drug costs in win for Biden

WASHINGTON, Aug 7 (Reuters) – The US Senate on Sunday passed a sweeping $430 billion bill intended to fight climate change, lower drug prices and raise some corporate taxes, a major victory for President Joe Biden that Democrats hope will aid their chances of keeping control of Congress in this year’s elections.

After a marathon, 27-hour weekend session of debate and Republican efforts to derail the package, the Senate approved the legislation known as the Inflation Reduction Act by a 51-50 party line vote Vice President Kamala Harris cast the tie-breaking ballot.

The action sends the measure to the House of Representatives for a vote expected Friday that could forward it, in turn, to the White House for Biden’s signature. In a statement, Biden urged the House to act as soon as possible and said he looked forward to signing the bill into law.

Register now for FREE unlimited access to Reuters.com

“The Senate is making history,” an elated Senate Majority Leader Chuck Schumer said, after pumping his fists in the air as cheered Democrats and their staff members responded to the vote with a standing ovation.

“To Americans who’ve lost faith that Congress can do big things, this bill is for you,” he said. “This bill is going to change America for decades.”

Schumer said the legislation contains “the boldest clean energy package in American history” to fight climate change while reducing consumer costs for energy and some medicines.

Democrats have drawn harsh attacks from Republicans over the legislation’s $430 billion in new spending and roughly $740 billion in new revenue. read more

Nevertheless, Democrats hope its passage, ahead of an August recess, will help the party’s House and Senate candidates in the Nov. 8 midterm elections at a time when Biden is suffering from anemic public approval ratings amid high inflation.

The legislation is aimed at reducing carbon emissions and shifting consumers to green energy, while cutting prescription drug costs for the elderly and tightening enforcement on taxes for corporations and the wealthy.

Because the measure pays for itself and reduces the federal deficit over time, Democrats contend that it will help bring down inflation, an economic liability that has also weighed on their hopes of retaining legislative control in the run-up to the 2024 presidential election.

Republicans, arguing that the bill will not address inflation, have denounced the measure as a job-killing, left-wing spending wish list that could undermine growth when the economy is in danger of falling into recession.

Democrats approved the bill by using a parliamentary maneuver called reconciliation, which allows budget-related legislation to avoid the 100-seat chamber’s 60-vote threshold for most bills and pass on a simple majority.

After several hours of debate, the Senate began a rapid-fire “vote-a-rama” on Democratic and Republican amendments on Saturday evening that stretched into Sunday afternoon.

Democrats repelled more than 30 Republican amendments, points of order and motions, all intended to scupper the legislation. Any change in the bill’s contents wrought by an amendment could have unraveled the Democrats’ 50-senator coalition needed to keep the legislation on track.

NO CAP ON INSULIN COSTS

But they were unable to muster the votes necessary to retain a provision to cap soaring insulin costs at $35 a month on the private health insurance market, which fell outside the reconciliation rules. Democrats said the legislation would still limit insulin costs for those on Medicare.

In a foreshadowing of the coming fall election campaign, Republicans used their amendment defeats to attack vulnerable Democrats who are seeking reelection in November.

“Democrats vote again to allow chaos on the southern border to continue,” Senate Republican leader Mitch McConnell said in a statement that named Democratic Senators Mark Kelly of Arizona, Catherine Cortez Masto of Nevada, Maggie Hassan of New Hampshire and Raphael Warnock of Georgia. All four are facing tight contests for reelection.

The bill was more than 18 months in the making as Biden’s original sweeping Build Back Better plan was whittled down in the face of opposition from Republicans and key legislators from his own party.

“It required many compromises. Doing important things almost always does,” Biden said in a statement.

Register now for FREE unlimited access to Reuters.com

Reporting by Richard Cowan, Rose Horowitch, David Morgan and Makini Brice; Editing by Scott Malone, Mary Milliken, Lisa Shumaker and Cynthia Osterman

Our Standards: The Thomson Reuters Trust Principles.

.

Categories
US

US Senate Democrats battle to pass $430 billion climate, drug bill

WASHINGTON, Aug 6 (Reuters) – The US Senate on Saturday began debating a Democratic bill to address key elements of President Joe Biden’s agenda – tackling climate change, lowering the costs of medication for the elderly and energy, while forcing corporations and the wealthy to pay more taxes.

The debate began after the Senate voted 51-50 to move ahead with the legislation. Vice President Kamala Harris broke a tie vote, with all 50 Republicans in opposition.

The Senate was set to debate the bill for up to 20 hours before diving into an arduous, time-consuming amendment process called a “vote-a-rama.”

Register now for FREE unlimited access to Reuters.com

Democrats and Republicans were poised to reject each other’s amendments, as Senate Majority Leader Chuck Schumer maneuvered to keep a his 50-member caucus united behind a bill that was negotiated over several months. If even one Democrat were to peel off, the entire effort would be doomed in the evenly split 50-50 Senate. read more

Earlier in the day, the Senate parliamentarian determined that the lion’s share of the healthcare provisions in the $430 billion bill could be passed with only a simple majority, bypassing a filibuster rule requiring 60 votes in the 100-seat chamber to advance most legislation and enabling Democrats to pass it over Republican objections.

Democrats hope that the legislation will give a boost to their candidates in the Nov. 8 midterm elections in which Biden’s party is in an uphill battle to retain its narrow control of the Senate and House of Representatives. The Democrats cast the legislation as a vehicle to combat inflation, a prime concern of US voters this year.

“The bill, when passed, will meet all of our goals: fighting climate change, lowering healthcare costs, closing tax loopholes abused by the wealthy and reducing the deficit,” Schumer said in a Senate speech.

There are three main parts to the bill’s tax provisions: a 15% minimum tax on corporations and the closing of loopholes that the wealthy can use to avoid paying taxes; tougher IRS enforcement; and a new excise tax on stock buybacks.

The legislation has $430 billion in new spending along with raising more than $740 billion in new revenues. read more

Democrats have said the legislation by 2030 would result in a 40% reduction in US carbon emissions, blamed for climate change.

‘PRICE-FIXING’

The measure would also allow the Medicare government health insurance program for the elderly to begin negotiating in 2026 with the pharmaceutical industry over prices on a limited number of prescription drug prices as a way of reducing costs. It also would place a $2,000-per-year cap on out-of-pocket medication costs under a Medicare drug program.

Senate Republican Leader Mitch McConnell attacked the provision involving negotiating drug prices, comparing it to past “price-fixing” attempts by countries such as Cuba, Venezuela and the former Soviet Union.

“Their policy would bring about a world where many fewer new drugs and treatments get invented in the first place as companies cut back on R&D,” McConnell said in a floor speech, referring to research and development.

While senators debated the policies embedded in the bill, its political ramifications were also on display.

In a speech at the Conservative Political Action Conference (CPAC) on Saturday, former President Donald Trump predicted fallout for Kyrsten Sinema and Joe Manchin, two key Democratic senators: “If this deal passes, they are both going to lose their next elections.”

But Manchin and Sinema are not up for re-election until 2024 and many of the provisions of the bill are popular with voters.

The legislation is a scaled-down version of a far broader, more expensive measure that many Democrats on the party’s left had hoped to approve last year. That measure stalled when Manchin, a centrist, balked, complaining that it would exacerbate inflationary pressures.

The bill calls for billions of dollars to encourage the production of more electric vehicles and foster clean energy, though automakers say sourcing rules will sharply limit how many electric vehicles qualify for tax credits.

It would also set $4 billion in new federal drought relief funds, a provision that could help the re-election campaigns of Democratic Senators Catherine Cortez Masto in Nevada and Mark Kelly in Arizona.

One provision cut from the bill would have forced drug companies to refund money to both government and private health plans if drug prices rise more quickly than inflation.

Independent Senator Bernie Sanders, a leading progressive, has criticized the bill for failing to go far enough and said he planned to offer amendments that would revive a series of social programs he pushed last year, including broadening the number of prescription drugs Medicare could negotiate prices on and providing government-subsidized dental, vision and hearing aid.

His amendments were expected to fail.

Republicans have signaled that they will offer amendments touching on other issues, including controlling immigrants coming across the US border with Mexico and enhancing policing to curtail rising crime rates in American cities since the onset of the COVID-19 pandemic.

Register now for FREE unlimited access to Reuters.com

Reporting by Richard Cowan and Makini Brice; additional reporting by Valerie Volcovici, David Shepardson and Kanishka Singh; Editing by Will Dunham, Scott Malone and Lisa Shumaker

Our Standards: The Thomson Reuters Trust Principles.

.

Categories
US

US charges four Kentucky police officers in Breonna Taylor killing

WASHINGTON, Aug 4 (Reuters) – US prosecutors on Thursday charged four current and former Louisville, Kentucky, police officers for their roles in the botched 2020 raid that killed Breonna Taylor, a Black woman who was in her home, in a case that sparked nationwide protests.

The charges represented the Justice Department’s latest effort to crack down on abuses and racial disparities in policing, following a wave of controversial police killings of Black Americans.

Former Louisville Metropolitan Police Department Detective Joshua Jaynes and current Sergeant Kyle Meany were charged with civil rights violations and obstruction of justice for using false information to obtain the search warrant that authorized the botched March 13, 2020, raid that killed Taylor in her home, the Justice Department said. Current Detective Kelly Goodlett was charged with conspiring with Jaynes to falsify the warrant and then cover up the falsification.

Register now for FREE unlimited access to Reuters.com

A fourth officer, former Detective Brett Hankison, was charged with civil rights violations for allegedly using excessive force, US Attorney Merrick Garland said.

“Breonna Taylor should be alive today,” Garland told a news conference. “The Justice Department is committed to defending and protecting the civil rights of every person in this country. That was this department’s founding purpose, and it remains our urgent mission.”

The death of Taylor, a 26-year-old emergency medical technician, was one in a trio of cases that fueled a summer of protests against racial injustice and police violence two years ago, in the early months of the COVID-19 pandemic.

“Today was a huge step toward justice,” lawyers for the Taylor family said in a statement following the news.

Louisville police on Thursday began the process of firing Meany and Goodlett, the department said in a statement. Hankison and Jaynes were previously fired by the department.

The Justice Department is also conducting an investigation into whether the Louisville Metro Government and Louisville police engaged in a pattern or practice of abusing residents’ civil rights.

NO KNOCK RAID

Louisville police were investigating alleged drug trafficking when they broke down the door of Taylor’s home in a “no-knock” raid, leading her boyfriend, who was carrying a legally owned firearm, to shoot at the officers, who then fired 22 shots into the apartment, killing Taylor, prosecutors said.

Hankison, prosecutors said, moved away from the door, firing 10 shots into Taylor’s apartment through a window and a glass door that were covered with blinds and curtains.

Hankison told a Kentucky grand jury that he opened fire once the shooting started. As he saw flashes light up the room, he said, he mistakenly believed one of the occupants was firing an assault-style rifle at his colleagues from him. Instead, mostly what he heard was other police firing their weapons. read more

Prosecutors said Jaynes and Goodlett met in a garage days after the shooting to agree on a false story to cover for the false evidence they had submitted to justify the botched raid.

Lawyer Stew Mathews, who represented Hankison at a trial in Jefferson County Circuit Court where he was acquitted in March of wanton endangerment, said he had spoken Thursday morning with the former detective as he was on his way to surrender to the FBI.

Mathews said the federal charges looked similar to the previous state charges Hankison had faced. Until Thursday, Hankison had been the only officer to face charges in connection with the raid.

“I’m sure Brett will be contesting this just like he did the other indication,” Mathews said.

Lawyer Thomas Clay, who represents Jaynes, could not be immediately reached for comment. It was not immediately clear if Meany and Goodlett had attorneys.

The killing of Taylor, along with other high-profile 2020 killings of George Floyd in Minneapolis and Ahmaud Arbery in Brunswick, Georgia, sparked nationwide protests.

Register now for FREE unlimited access to Reuters.com

Reporting by Scott Malone in Washington and Colleen Jenkins in Winston-Salem, North Carolina; Editing by Daniel Wallis and Marla Dickerson

Our Standards: The Thomson Reuters Trust Principles.

.

Categories
US

US declares monkeypox outbreak a public health emergency

Aug 4 (Reuters) – The United States has declared monkeypox a public health emergency, the health secretary said on Thursday, a move expected to free up additional funding and tools to fight the disease.

The US tally topped 6,600 on Wednesday, almost all of the cases among men who have sex with men.

“We’re prepared to take our response to the next level in addressing this virus, and we urge every American to take monkeypox seriously,” Health and Human Services Secretary Xavier Becerra said at a briefing.

Register now for FREE unlimited access to Reuters.com

The declaration will improve the availability of data on monkeypox infections that is needed for the response, US Centers for Disease Control and Prevention Director Rochelle Walensky said, speaking alongside Bacerra.

The US government has come under pressure for its handling of the outbreak.

The disease began spreading in Europe before moving to the United States, which now has the most cases in the world. Vaccines and treatments have been in short supply and the disease often left for historically underfunded sexual health clinics to manage. read more

The World Health Organization declared monkeypox a “public health emergency of international concern,” its highest alert level. The WHO declaration last month sought to trigger a coordinated international response and unlock funding to collaborate on vaccines and treatments. read more

Governments are deploying vaccines and treatments that were first approved for smallpox but also work for monkeypox.

The US government has distributed 600,000 doses of Bavarian Nordic’s (BAVA.CO) Jynneos vaccine and deployed 14,000 of Siga Technologies’ (SIGA.O) TPOXX treatment, officials said, though they did not disclose how many have been administered.

Walensky said the government aims to vaccinate more than 1.6 million high-risk individuals.

US Food and Drug Administration Commissioner Robert Califf said the agency was considering freeing up more Jynneos vaccine doses by allowing doctors to draw 5 doses of vaccine from each vial instead of the current 1 dose by using a different subcutaneous method of inoculation.

US President Joe Biden this month appointed two federal officials to coordinate his administration’s response to monkeypox, following declarations of emergencies by California, Illinois and New York. read more

First identified in monkeys in 1958, the disease has mild symptoms including fever, aches and pus-filled skin lesions, and people tend to recover from it within two to four weeks, the WHO says. It spreads through close physical contact and is rarely fatal.

Anthony Fauci, Biden’s chief medical adviser, told Reuters on Thursday that it was critical to engage leaders from the gay community as part of efforts to rein in the outbreak, but cautioned against stigmatizing the lifestyle.

“Engagement of the community has always come to be successful,” Fauci said.

Register now for FREE unlimited access to Reuters.com

Reporting by Manas Mishra and Amruta Khandekar in Bengaluru, Ismail Shakil in Ottawa, Caroline Humer and Leela de Kretser, Editing by Anil D’Silva, Deepa Babington and Howard Goller

Our Standards: The Thomson Reuters Trust Principles.

.

Categories
Technology

Apple drops mask requirements for most of its corporate workers – The Verge

People await the start of a product launch event at Apple’s new campus in Cupertino, California, US September 12, 2017. REUTERS/Stephen Lam

Register now for FREE unlimited access to Reuters.com

Aug 1 (Reuters) – Apple Inc is dropping its mask mandate for corporate employees at most locations, the Verge reported on Monday, citing an internal memo. (https://bit.ly/3oJ3EQN)

This comes even as COVID-19 infections in the United States have been on the rise with the BA.4 and BA.5 subvariants of the Omicron variant accounting for more than 90% of infections, according to the US Centers for Disease Control and Prevention .

These subvariants have significant mutations from the earliest versions of Omicron and protection from vaccines wanes over time.

“Don’t hesitate to continue wearing a face mask if you feel more comfortable doing so,” the report quoted Apple as saying in the internal email. “Also, please respect every individual’s decision to wear a mask or not.”

Apple did not immediately respond to Reuters’ request for comment outside regular business hours.

Register now for FREE unlimited access to Reuters.com

Reporting by Kanjyik Ghosh in Bengaluru; Editing by Subhranshu Sahu

Our Standards: The Thomson Reuters Trust Principles.

.